JOSHUA STONE: Open Payments
NPI 1629411095 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 55 payments from 12 companies in 2025. Trend: 2023 $669 · 2024 $927 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $145 |
| Novo Nordisk Inc | 4 | $77 |
| Ardelyx, Inc. | 3 | $60 |
| Amgen Inc. | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: CAPLYTA, UBRELVY, VRAYLAR, IBSRELA, OTEZLA, Rybelsus, QULIPTA, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
